ConductScience.org, home

Paper39189232

Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development.

Jucaud V. Antibodies (Basel), 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development. Papers, record 39189232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39189232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development.
PubMed
Journal
Antibodies (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.34, provisional
iCite
Revised in PubMed
2024-08-30
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jucaud VVadimhttps://orcid.org/0000-0003-0385-2623

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R21 EB034423NIBIB NIH HHSUnited StatesR21EB034423PubMed and NIHNIH RePORTER
NATerasaki Institute for Biomedical InnovationPubMedPubMed
1R21EB034423-01A1NIH HHSUnited StatesR21EB034423PubMed and NIHNIH RePORTER

Download CSV of grants

References93

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119920778Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.Transplantation2009https://conductscience.org/library/papers/19920778PubMed
215032593T lymphocyte-endothelial cell interactions.Annu Rev Immunol2004https://conductscience.org/library/papers/15032593PubMed
324868561Predicting alloreactivity in transplantation.J Immunol Res2014https://conductscience.org/library/papers/24868561PubMed
432227681HLA-EMMA: A user-friendly tool to analyse HLA class I and class II compatibility on the amino acid level.HLA2020https://conductscience.org/library/papers/32227681PubMed
538239050Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodies.HLA2024https://conductscience.org/library/papers/38239050PubMed
620408898MHC class II epitope predictive algorithms.Immunology2010https://conductscience.org/library/papers/20408898PubMed
726870045Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen.Front Immunol2016https://conductscience.org/library/papers/26870045PubMed
827617489Aptamer-Based Microfluidic Electrochemical Biosensor for Monitoring Cell-Secreted Trace Cardiac Biomarkers.Anal Chem2016https://conductscience.org/library/papers/27617489PubMed
928265064Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28265064PubMed
1033776988Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.Front Immunol2020https://conductscience.org/library/papers/33776988PubMed
1112216939Pathways of allorecognition: implications for transplantation tolerance.Transpl Immunol2002https://conductscience.org/library/papers/12216939PubMed
1236072942Impact of DSA and immunosuppression minimization on rejection, graft, and patient survival after simultaneous liver-kidney transplantation.Front Med (Lausanne)2022https://conductscience.org/library/papers/36072942PubMed
1331867849Development and outcomes of de novo donor-specific antibodies in low, moderate, and high immunological risk kidney transplant recipients.Am J Transplant2020https://conductscience.org/library/papers/31867849PubMed
1430429288Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential.J Immunol2018https://conductscience.org/library/papers/30429288PubMed
1525708017HLA epitopes as viewed by antibodies: what is it all about?Am J Transplant2015https://conductscience.org/library/papers/25708017PubMed
1629243394
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.
Am J Transplant2018https://conductscience.org/library/papers/29243394PubMed
1728378521Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation.HLA2017https://conductscience.org/library/papers/28378521PubMed
1812780557Humoral theory of transplantation.Am J Transplant2003https://conductscience.org/library/papers/12780557PubMed
1934420780Clinical Outcome of Kidney Transplant Patients on the Allograft Function, Loss, Effects of HLA-DQB1-DSA+, and Graft Survival.Transplant Proc2021https://conductscience.org/library/papers/34420780PubMed
2036186822The natural history of de novo donor-specific HLA antibodies after kidney transplantation.Front Med (Lausanne)2022https://conductscience.org/library/papers/36186822PubMed

See all 93 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41659507Profiling Allogeneic HLA-specific B-cell Responses Utilizing a 64-plex Single-HLA Reporter Cell Panel.bioRxiv2026https://conductscience.org/library/papers/41659507PubMed
41656988Liver Tissueoid on-a-Chip Modeling Liver Regeneration and Allograft Rejection.Adv Mater2026https://conductscience.org/library/papers/41656988PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39189232

GET https://conductscience.org/api/papers/v1/39189232/references?page=2